Navigation Links
NIH awards Rutgers $47.5 million to advance groundbreaking research on protein structures
Date:9/30/2010

eaching institute jointly administered by Rutgers and the University of Medicine and Dentistry of New Jersey. Both are also faculty in the Rutgers School of Arts and Sciences.

NIH funding for the third phase of the PSI, known as PSI:Biology, is through the agency's National Institute of General Medical Sciences (NIGMS), which supports basic research to increase understanding of life processes and lay the foundation for advances in disease diagnosis, treatment and prevention. The PSI:Biology phase will use methods developed during the PSI's first decade to generate protein structures that can help guide functional studies by laboratories around the world. For example, in addition to its primary focus on networks of human proteins associated with cancer biology, the NESG consortium will collaborate with groups around the country to determine structures of proteins involved in various aspects of cell biology, such as gene regulation, metabolism, and the engineering of novel proteins.

"Another key goal of the initiative is to make the resources generated by the PSI available to the broader scientific community," said Ward Smith, director of the PSI: Biology program. "These Rutgers efforts are key to achieving this goal the NESG will partner with biologists to solve functional studies while the SBKB will put all the PSI's results at one's fingertips."


'/>"/>

Contact: Carl Blesch
cblesch@ur.rutgers.edu
732-932-7084 x616
Rutgers University
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. NIH doles out $3M in new innovator awards to 2 UC San Diego faculty
2. NIH awards Clemson bioengineer $1.5 million to improve durability of tissue heart valves
3. Entertainment Software Association Foundation awards grant to FAS for immune attack
4. Audience Selected as Silver Winner in This Years Wall Street Journal Technology Innovation Awards and Winner of the Semiconductors Category
5. NIAID announces 25 new awards to develop radiation countermeasures
6. Human Microbiome Project awards funds for technology development, data analysis and ethical research
7. University success at national engineering awards
8. New Systems Biology Awards enable detailed study of microbes
9. Soil Science Society of America presents awards in Houston
10. ASU researchers receive NIH awards for studies of malaria and emergent disease
11. NIH funds 16 Science Education Partnership Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... pathogens are growing increasingly resistant to the conventional antibiotics ... scientists has synthesized a potent new class of compounds ... , Writing online in the Journal of the ... of Wisconsin-Madison chemistry Professor Helen Blackwell describes agents that ... Staphylococcus aureus , a bacterium at the root of ...
(Date:5/22/2013)... cell powered buses, including a team from Simon ... processes and bus membrane durability. , The team ... in the operating cycle of the bus on ... study, led by SFU graduate student Natalia MaCauley, ... Burnaby-based Ballard Power Systems and funded by Automotive ...
(Date:5/22/2013)... (May 22, 2013)The omega 3 fatty acids in fish ... diseaseso much so that the American Heart Association currently ... week, particularly fatty varieties rich in omega 3s. However, ... mystery. In a new study, scientists led by Jason ... this phenomenon by providing evidence that fish oil might ...
Breaking Biology News(10 mins):University of Wisconsin chemists find new compounds to curb staph infection 2Tests lead to doubling of fuel cell life 2Fish oil may help the heart beat mental stress 2
... your goal, you can't do better than to emulate a ... an unusual pitching stroke that allows the bug to hover ... a marvel of engineering. , Z. Jane Wang, professor of ... on flying systems and fluid dynamics today (Feb. 19) at ...
... drinkers who continue to imbibe after learning they are pregnant ... to those of abstainers or quitters, says a new study. ... the findings reveal effects of drinking on the developing human ... Alcoholism: Clinical and Experimental Research . , "What ...
... mention the cleaning product industry, repeatedly warn of their ... is raising the intriguing idea that persistent bacterial and ... Robert W. and Vivian K. Cahill Professor in Cancer ... an essay in the Feb. 24 issue of the ...
Cached Biology News:Scientist uses dragonflies to better understand flight 2Ultrasounds show mothers' drinking shrinks fetal brain 2Scientists look to the Bahamas as a model for coral reef conservation 2Scientists look to the Bahamas as a model for coral reef conservation 3
(Date:5/23/2013)... MENLO PARK, Calif. , May 23, 2013 /PRNewswire/ ... an oral treatment for pain has reached an important ... clinical trial of VBY-036 - a selective cathepsin S ... of VBY-036 is a double-blind, randomized, placebo-controlled study designed ... escalating doses of VBY-036 in healthy adults. ...
(Date:5/23/2013)... Z Trim Holdings, Inc. (OTC Markets: ZTHO), ... of industries, announced that Chef Erin Ryan ... year,s National Restaurant Association ("NRA") NRA Show, which was ... Research Chefs Association.  Chef Ryan spoke on the subject ... and the Ugly," joining four other prestigious panelists including: ...
(Date:5/23/2013)... May 23, 2013 Pressure BioSciences, Inc. (OTCQB: ... Company will host a teleconference to discuss its First ... update. The teleconference information is provided below: ... Daylight Time (EDT) Dial-in: (800) 875-3456 (U.S.); ... (Int,l) Passcode: VS22823 For those unable to ...
(Date:5/23/2013)... 2013 Pusan National University Yangsan Hospital, ... and contract research company focused on research and ... today a publication reporting the induction of functional ... and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex Inc.). ... the May 15 th , 2013 issue of ...
Breaking Biology Technology:Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3
... , , SAN ... J. Fox Foundation will provide partial funds for long-term follow-up testing ... for Parkinson,s disease. The funding will enable Ceregene to collect ... patients with advanced Parkinson,s disease who were enrolled in the double-blind, ...
... , , , , ... OPTR ) today reported financial results for the second quarter ended June ... of 2009 of $12.4 million, or $0.37 per share, which was in ... the second quarter of 2008 of $8.1 million, or $0.29 per share. ...
... Inc. (NASDAQ: AEZS , TSX: AEZ), a global ... its second quarter 2009 financial and operating results before market ... a conference call and webcast to discuss these results later ... may access the live webcast via the Company,s website at ...
Cached Biology Technology:Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients 2Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients 3Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients 4Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results 2Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results 3Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results 4Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results 5Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results 6